Relapse prevention strategies

Relapse Prevention - The Ground Rules

• Goal: Move from acute stabilization to stable remission by equipping patients to handle high-risk situations.
• Core Models:
  • Cenaps Model (Gorski): Views relapse as a progression of warning signs.
  • Cognitive-Behavioral Model (Marlatt): Focuses on coping skills in high-risk situations.
• Abstinence Violation Effect (AVE): A minor slip (lapse) leads to guilt & perceived loss of control, escalating to a full-blown relapse. This is often driven by "all-or-nothing" thinking.

⭐ High-Yield Fact: The most common triggers for relapse are negative emotional states (e.g., frustration, anger, depression), interpersonal conflict, and social pressure.

Psychosocial Strategies - Talk It Through

• Cognitive Behavioral Therapy (CBT): The cornerstone of relapse prevention.

  • Goal: Identify and modify maladaptive thoughts, feelings, and behaviors linked to substance use.
  • Core Technique: Functional analysis of substance use (triggers, thoughts, consequences).
  • Develops coping skills for high-risk situations and cravings.

• Motivational Interviewing (MI): A collaborative conversation style for strengthening a person’s own motivation and commitment to change.

  • 📌 OARS Core Skills: Open-ended questions, Affirmations, Reflective listening, Summaries.

• Support Groups (AA/NA): Peer-led, 12-step programs providing fellowship and accountability.

• Contingency Management: Uses positive reinforcement (e.g., vouchers) for objective evidence of abstinence.

⭐ Exam Favorite: Contingency management is highly effective, especially for stimulant (cocaine, amphetamine) use disorders, by providing tangible rewards for maintaining abstinence.

Pharmacotherapy - The Chemical Shield

• Alcohol Use Disorder

  • Naltrexone: Reduces cravings & the rewarding "buzz" (μ-opioid antagonist).
  • Acamprosate (Campral): Restores GABA/glutamate balance. Ideal for post-detoxification maintenance.
  • Disulfiram (Antabuse): Aversive therapy. Inhibits aldehyde dehydrogenase → acetaldehyde buildup. ⚠️ Requires high motivation.

• Opioid Use Disorder

  • Naltrexone: Blocks euphoric effects. Must be opioid-free for 7-10 days.
  • Buprenorphine (+ Naloxone): Partial μ-agonist with a ceiling effect on respiratory depression.
  • Methadone: Long-acting full μ-agonist. Dispensed via licensed programs. ⚠️ Monitor for QTc prolongation.

• Nicotine Use Disorder

  • Varenicline (Chantix): Partial nicotinic receptor agonist. Most effective monotherapy.
  • Bupropion (Zyban): NDRI antidepressant.
  • 📌 Mnemonic: "He CAN't smoke": Campral, Antabuse, Naltrexone for alcohol.

⭐ Exam Favorite: Always ensure a patient is opioid-free for at least 7-10 days before starting naltrexone to avoid severe, precipitated withdrawal symptoms. This is a critical safety step.

High‑Yield Points - ⚡ Biggest Takeaways

• Relapse is an expected part of recovery, not a failure; the goal is to re-engage with treatment and learn from the event.
• Use the HALT mnemonic to identify high-risk situations: Hungry, Angry, Lonely, and Tired.
• Cognitive Behavioral Therapy (CBT) is key to developing coping skills and changing maladaptive behaviors.
• Contingency management uses positive reinforcement to maintain abstinence.
• Support groups like AA/NA provide essential peer support.